FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Habibe Karacay

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Concepts & Ideas

Tissue Distribution

Anatomy

Tumor Cell Line

Disorders

Colonic Neoplasms

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Robert M Sharkey; Catharina M van Rij; Otto C Boerman; Thomas M Cardillo; Chien-Hsing Chang; Cathelijne Frielink; Habibe Karacay; William J McBride; Celeste Regino; Edmund A Rossi; David M Goldenberg
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers.
William J McBride; Robert M Sharkey; Christopher A D'Souza; Habibe Karacay; David M Goldenberg
New lyophilized kit for rapid radiofluorination of peptides.
Robert M Sharkey; Serengulam V Govindan; Habibe Karacay; David M Goldenberg
Combination radioimmunotherapy and chemoimmunotherapy involving different or the same targets improves therapy of human pancreatic carcinoma xenograft models.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Habibe Karacay (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: Robert M Sharkey; Catharina M van Rij; Otto C Boerman; Thomas M Cardillo; Chien-Hsing Chang; Cathelijne Frielink; Habibe Karacay; William J McBride; Celeste Regino; Edmund A Rossi; David M Goldenberg
A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(10):1625-32.
2012: William J McBride; Robert M Sharkey; Christopher A D'Souza; Habibe Karacay; David M Goldenberg
New lyophilized kit for rapid radiofluorination of peptides.
Bioconjugate chemistry 2012;23(3):538-47.
2011: Robert M Sharkey; Serengulam V Govindan; Habibe Karacay; David M Goldenberg
Combination radioimmunotherapy and chemoimmunotherapy involving different or the same targets improves therapy of human pancreatic carcinoma xenograft models.
Molecular cancer therapeutics 2011;10(6):1072-81.
2011: Habibe Karacay; Robert M Sharkey; William J McBride; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(4):555-9.
2010: William J McBride; Christopher A D'Souza; Robert M Sharkey; Habibe Karacay; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex.
Bioconjugate chemistry 2010;21(7):1331-40.
2010: Robert M Sharkey; Habibe Karacay; David M Goldenberg
Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.
Cancer 2010;116(4 Suppl):1134-45.
2009: Habibe Karacay; Robert M Sharkey; David V Gold; Dan R Ragland; William J McBride; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(12):2008-16.
2009: William J McBride; Robert M Sharkey; Habibe Karacay; Christopher A D'Souza; Edmund A Rossi; Peter Laverman; Chien-Hsing Chang; Otto Boerman; David M Goldenberg
A novel method of 18F radiolabeling for PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(6):991-8.
2009: Robert M Sharkey; Habibe Karacay; Christine R Johnson; Samuel Litwin; Edmund A Rossi; William J McBride; Chien-Hsing Chang; David M Goldenberg
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(3):444-53.
2008: M Jules Mattes; Robert M Sharkey; Habibe Karacay; Myron S Czuczman; David M Goldenberg
Therapy of advanced B-lymphoma xenografts with a combination of 90Y-anti-CD22 IgG (epratuzumab) and unlabeled anti-CD20 IgG (veltuzumab).
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6154-60.
2008: Robert M Sharkey; Habibe Karacay; Samuel Litwin; Edmund A Rossi; William J McBride; Chien-Hsing Chang; David M Goldenberg
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.
Cancer research 2008;68(13):5282-90.
2008: David V Gold; David M Goldenberg; Habibe Karacay; Edmund A Rossi; Chien-Hsing Chang; Thomas M Cardillo; William J McBride; Robert M Sharkey
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Cancer research 2008;68(12):4819-26.
2008: Robert M Sharkey; Habibe Karacay; Shankar Vallabhajosula; William J McBride; Edmund A Rossi; Chien-Hsing Chang; Stanley J Goldsmith; David M Goldenberg
Metastatic human colonic carcinoma: molecular imaging with pretargeted SPECT and PET in a mouse model.
Radiology 2008;246(2):497-507.
2007: Robert M Sharkey; Habibe Karacay; William J McBride; Edmund A Rossi; Chien-Hsing Chang; David M Goldenberg
Bispecific antibody pretargeting of radionuclides for immuno single-photon emission computed tomography and immuno positron emission tomography molecular imaging: an update.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5577s-5585s.
2007: Pierre-Yves Brard; Habibe Karacay; Rhona Stein; Robert M Sharkey; M Jules Mattes; Chien-Hsing Chang; Edmund A Rossi; William J McBride; David M Goldenberg
A divalent hapten-peptide induces apoptosis in human non hodgkin lymphoma cell lines targeted by anti-CD20xanti-hapten bispecific antibodies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5564s-5571s.
2006: William J McBride; Pat Zanzonico; Robert M Sharkey; Carl Norén; Habibe Karacay; Edmund A Rossi; Michele J Losman; Pierre-Yves Brard; Chien-Hsing Chang; Steven M Larson; David M Goldenberg
Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1678-88.
2005: Habibe Karacay; Pierre-Yves Brard; Robert M Sharkey; Chien-Hsing Chang; Edmund A Rossi; William J McBride; Dan R Ragland; Ivan D Horak; David M Goldenberg
Therapeutic advantage of pretargeted radioimmunotherapy using a recombinant bispecific antibody in a human colon cancer xenograft.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7879-85.
2005: Robert M Sharkey; Thomas M Cardillo; Edmund A Rossi; Chien-Hsing Chang; Habibe Karacay; William J McBride; Hans J Hansen; Ivan D Horak; David M Goldenberg
Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody.
Nature medicine 2005;11(11):1250-5.
2005: Edmund A Rossi; Chien-Hsing Chang; Michele J Losman; Robert M Sharkey; Habibe Karacay; William McBride; Thomas M Cardillo; Hans J Hansen; Zhengxing Qu; Ivan D Horak; David M Goldenberg
Pretargeting of carcinoembryonic antigen-expressing cancers with a trivalent bispecific fusion protein produced in myeloma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7122s-7129s.
2005: Robert M Sharkey; Habibe Karacay; Thomas M Cardillo; Chien-Hsing Chang; William J McBride; Edmund A Rossi; Ivan D Horak; David M Goldenberg
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 2):7109s-7121s.
2005: David E Modrak; Habibe Karacay; Thomas M Cardillo; Guy Newsome; David M Goldenberg; David V Gold
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
International journal of oncology 2005;26(6):1591-6.
2005: Robert M Sharkey; Habibe Karacay; Chien-Hsing Chang; William J McBride; Ivan D Horak; David M Goldenberg
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody.
Leukemia 2005;19(6):1064-9.
2004: Thomas M Cardillo; Habibe Karacay; David M Goldenberg; Dion Yeldell; Chien-Hsing Chang; David E Modrak; Robert M Sharkey; David V Gold
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(10):3552-61.
2004: Gary L Griffiths; Chien-Hsing Chang; William J McBride; Edmund A Rossi; Agatha Sheerin; German R Tejada; Habibe Karacay; Robert M Sharkey; Ivan D Horak; Hans J Hansen; David M Goldenberg
Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(1):30-9.
2003: Robert M Sharkey; Habibe Karacay; Heidi Richel; William J McBride; Edmund A Rossi; Ken Chang; Dion Yeldell; Gary L Griffiths; Hans J Hansen; David M Goldenberg
Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3897S-913S.
2003: Edmund A Rossi; Robert M Sharkey; William McBride; Habibe Karacay; Li Zeng; Hans J Hansen; David M Goldenberg; Chien-Hsing Chang
Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 2):3886S-96S.
2003: David M Goldenberg; Chien-Hsing Chang; Robert M Sharkey; Edmund A Rossi; Habibe Karacay; William McBride; Hans J Hansen; Jean-François Chatal; Jacques Barbet
Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?
European journal of nuclear medicine and molecular imaging 2003;30(5):777-80.
2003: Robert M Sharkey; William J McBride; Habibe Karacay; Ken Chang; Gary L Griffiths; Hans J Hansen; David M Goldenberg
A universal pretargeting system for cancer detection and therapy using bispecific antibody.
Cancer research 2003;63(2):354-63.
2002: Habibe Karacay; Robert M Sharkey; William J McBride; Gary L Griffiths; Z Qu; Ken Chang; Hans J Hansen; David M Goldenberg
Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
Bioconjugate chemistry 2002;13(5):1054-70.
2002: Chien-Hsing Chang; Robert M Sharkey; Edmund A Rossi; Habibe Karacay; William McBride; Hans J Hansen; Jean-François Chatal; Jacques Barbet; David M Goldenberg
Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.
Molecular cancer therapeutics 2002;1(7):553-63.
2000: Habibe Karacay; William J McBride; Gary L Griffiths; Robert M Sharkey; Jacques Barbet; Hans J Hansen; David M Goldenberg
Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Bioconjugate chemistry 2000;11(6):842-54.
1999: Serengulam V Govindan; M Jules Mattes; R Stein; B J McBride; Habibe Karacay; David M Goldenberg; Hans J Hansen; Gary L Griffiths
Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids.
Bioconjugate chemistry 1999;10(2):231-40.
1998: Serengulam V Govindan; LB Shih; David M Goldenberg; Robert M Sharkey; Habibe Karacay; J E Donnelly; Michele J Losman; Hans J Hansen; Gary L Griffiths
90Yttrium-labeled complementarity-determining-region-grafted monoclonal antibodies for radioimmunotherapy: radiolabeling and animal biodistribution studies.
Bioconjugate chemistry 1998;9(6):773-82.
1998: Habibe Karacay; GL Ong; Hans J Hansen; Gary L Griffiths; D M Goldenberg; M Jules Mattes
Intracellular processing of 99Tcm-antibody conjugates.
Nuclear medicine communications 1998;19(10):971-9.
1997: Robert M Sharkey; Habibe Karacay; Gary L Griffiths; Thomas M Behr; Rosalyn D Blumenthal; M Jules Mattes; Hans J Hansen; David M Goldenberg
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Bioconjugate chemistry 1997;8(4):595-604.
1997: Habibe Karacay; Robert M Sharkey; Serengulam V Govindan; William J McBride; David M Goldenberg; Hans J Hansen; Gary L Griffiths
Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
Bioconjugate chemistry 1997;8(4):585-94.
1995: SO Leung; Habibe Karacay; Michele J Losman; Gary L Griffiths; David M Goldenberg; Hans J Hansen
Bacterial expression of a kemptide fusion protein facilitates 32P labeling of a humanized, anti-carcinoembryonic antigen (hMN-14) antibody fragment.
Cancer research 1995;55(23 Suppl):5968s-5972s.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.